1. The symptom phenotype of oncology outpatients remains relatively stable from prior to through 1 week following chemotherapy. (18th January 2016) Authors: Miaskowski, C.; Cooper, B.A.; Aouizerat, B.; Melisko, M.; Chen, L.‐M.; Dunn, L.; Hu, X.; Kober, K.M.; Mastick, J.; Levine, J.D.; Hammer, M.; Wright, F.; Harris, J.; Armes, J.; Furlong, E.; Fox, P.; Ream, E.; Maguire, R.; Kearney, N. Journal: European journal of cancer care Issue: Volume 26:Number 3(2017:May) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Unintended bias in clinical trials: The prevalence of entry criteria that exclude patients with invasive lobular carcinoma from metastatic breast cancer trials. (October 2020) Authors: Abel, M.K.; Diaz, I.; Levine, J.; Pate, L.; Viggiano, E.; Melisko, M.; Mukhtar, R. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 1 Page Start: S69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗